Institute for Emergency and Disaster Medicine, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, No. 32, Yi Huan Lu Xi Er Duan, Chengdu, 610072, Sichuan Province, China.
Chinese Academy of Sciences, Sichuan Translational Medicine Research Hospital, Chengdu, 610072, China.
World J Emerg Surg. 2023 Mar 14;18(1):17. doi: 10.1186/s13017-023-00487-7.
During medical emergencies, intraosseous (IO) access and intravenous (IV) access are methods of administering therapies and medications to patients. Treating patients in emergency medical situations is a highly time sensitive practice; however, research into the optimal access method is limited and existing systematic reviews have only considered out-of-hospital cardiac arrest (OHCA) patients. We focused on severe trauma patients and conducted a systematic review to evaluate the efficacy and efficiency of intraosseous (IO) access compared to intravenous (IV) access for trauma resuscitation in prehospital care.
PubMed, Web of Science, Cochrane Library, EMBASE, ScienceDirect, banque de données en santé publique and CNKI databases were searched for articles published between January 1, 2000, and January 31, 2023. Adult trauma patients were included, regardless of race, nationality, and region. OHCA patients and other types of patients were excluded. The experimental and control groups received IO and IV access, respectively, in the pre-hospital and emergency departments for salvage. The primary outcome was success rate on first attempt, which was defined as secure needle position in the marrow cavity or a peripheral vein, with normal fluid flow. Secondary outcomes included mean time to resuscitation, mean procedure time, and complications.
Three reviewers independently screened the literature, extracted the data, and assessed the risk of bias in the included studies; meta-analyses were then performed using Review Manager (Version 5.4; Cochrane, Oxford, UK). The success rate on first attempt was significant higher for IO access than for IV access (RR = 1.46, 95% CI [1.16, 1.85], P = 0.001). The mean procedure time was significantly reduced (MD = - 5.67, 95% CI [- 9.26, - 2.07], P = 0.002). There was no significant difference in mean time to resuscitation (MD = - 1.00, 95% CI [- 3.18, 1.17], P = 0.37) and complications (RR = 1.22, 95% CI [0.14, 10.62], P = 0.86) between the IO and IV groups.
The success rate on first attempt of IO access was much higher than that of IV access for trauma patients, and the mean procedure time of IO access was significantly less when compared to IV access. Therefore, IO access should be suggested as an urgent vascular access for hypotensive trauma patients, especially those who are under severe shock.
在医疗急救中,骨髓内(IO)通路和静脉(IV)通路是向患者给药和治疗的方法。在紧急医疗情况下治疗患者是一项高度注重时间的实践;然而,关于最佳通路方法的研究有限,现有的系统评价仅考虑了院外心脏骤停(OHCA)患者。我们专注于严重创伤患者,并进行了一项系统评价,以评估在院前护理中与 IV 通路相比,骨髓内(IO)通路用于创伤复苏的疗效和效率。
在 2000 年 1 月 1 日至 2023 年 1 月 31 日期间,我们在 PubMed、Web of Science、Cochrane 图书馆、EMBASE、ScienceDirect、banque de données en santé publique 和 CNKI 数据库中搜索了已发表的文章。纳入了成年创伤患者,无论种族、国籍和地区如何。排除了 OHCA 患者和其他类型的患者。实验和对照组分别在院前和急诊科接受 IO 和 IV 通路,以进行抢救。主要结局是首次尝试的成功率,定义为骨髓腔内或外周静脉内安全的针位和正常的液体流动。次要结局包括复苏平均时间、平均手术时间和并发症。
三名审查员独立筛选文献、提取数据并评估纳入研究的偏倚风险;然后使用 Review Manager(版本 5.4;Cochrane,牛津,英国)进行荟萃分析。与 IV 通路相比,IO 通路的首次尝试成功率显著更高(RR=1.46,95%CI[1.16,1.85],P=0.001)。平均手术时间明显缩短(MD=-5.67,95%CI[-9.26,-2.07],P=0.002)。复苏平均时间(MD=-1.00,95%CI[-3.18,1.17],P=0.37)和并发症(RR=1.22,95%CI[0.14,10.62],P=0.86)方面,IO 组与 IV 组之间无显著差异。
与 IV 通路相比,IO 通路用于创伤患者的首次尝试成功率要高得多,而与 IV 通路相比,IO 通路的平均手术时间明显更短。因此,建议将 IO 通路作为低血压创伤患者,尤其是严重休克患者的紧急血管通路。